Peetz Christopher 4
4 · Mirum Pharmaceuticals, Inc. · Filed Nov 20, 2025
Insider Transaction Report
Form 4
Peetz Christopher
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2025-11-18−19,133→ 150,867 totalExercise: $19.24Exp: 2030-01-09→ Common Stock (19,133 underlying) - Exercise/Conversion
Common Stock
2025-11-18$19.24/sh+19,133$368,119→ 158,034 total
Holdings
- 208,570(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Includes 260 shares of Common Stock that were acquired by the Reporting Person on November 10, 2025, pursuant to the Issuer's Employee Stock Purchase Plan.
- [F2]The stock option is fully vested.